180 related articles for article (PubMed ID: 11268451)
21. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
22. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D
Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542
[TBL] [Abstract][Full Text] [Related]
23. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment.
Ikeguchi M; Nakamura S; Kaibara N
Oncol Rep; 2002; 9(5):1121-6. PubMed ID: 12168083
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
26. Ionizing radiation induces a p53-dependent apoptotic mechanism in ARPE-19 cells.
Jiang YL; Escaño MF; Sasaki R; Fujii S; Kusuhara S; Matsumoto A; Sugimura K; Negi A
Jpn J Ophthalmol; 2004; 48(2):106-14. PubMed ID: 15064971
[TBL] [Abstract][Full Text] [Related]
27. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of p21(WAF-1/CIP-1) in the lens epithelium of rat sugar cataract.
Takamura Y; Kubo E; Tsuzuki S; Yagi H; Sato M; Akagi Y
Exp Eye Res; 2002 Feb; 74(2):245-54. PubMed ID: 11950235
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
30. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
Divan A; Lawry J; Dunsmore IR; Parsons MA; Royds JA
Cancer Res; 2001 Apr; 61(7):3157-63. PubMed ID: 11306502
[TBL] [Abstract][Full Text] [Related]
31. [Effect of ZGDHu-1 on proliferation and apoptosis of A549 cells in vitro and antitumor activity in vivo].
Zhou YL; Hu WX; Lü YP; Qiu LN; Wang WS; Yang ZY; Liu JD; Rao GW
Yao Xue Xue Bao; 2007 Jan; 42(1):26-34. PubMed ID: 17520803
[TBL] [Abstract][Full Text] [Related]
32. Restoration of p53 function in anaplastic Wilms' tumor.
Delatte SJ; Hazen-Martin DJ; Re GG; Kelly JR; Sutphin A; Tagge EP
J Pediatr Surg; 2001 Jan; 36(1):43-50. PubMed ID: 11150436
[TBL] [Abstract][Full Text] [Related]
33. Expression of MIB and BCL-2 in patients with nephrogenic rests with and without associated Wilms' tumors.
Wünsch L; Flemming P; Glüer S
Eur J Pediatr Surg; 2001 Apr; 11(2):105-9. PubMed ID: 11371029
[TBL] [Abstract][Full Text] [Related]
34. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
[TBL] [Abstract][Full Text] [Related]
35. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
[TBL] [Abstract][Full Text] [Related]
36. Genetic alterations of WWOX in Wilms' tumor are involved in its carcinogenesis.
Płuciennik E; Nowakowska M; Wujcicka WI; Sitkiewicz A; Kazanowska B; Zielińska E; Bednarek AK
Oncol Rep; 2012 Oct; 28(4):1417-22. PubMed ID: 22842668
[TBL] [Abstract][Full Text] [Related]
37. Expression of multidrug resistance-related markers in gastric cancer.
Fan K; Fan D; Cheng LF; Li C
Anticancer Res; 2000; 20(6C):4809-14. PubMed ID: 11205224
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
39. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
[TBL] [Abstract][Full Text] [Related]
40. A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profile.
Feller N; Hoekman K; Kuiper CM; Linn SC; Verheul HM; Wolthers BG; Popp-Snijders C; Pinedo HM
Clin Cancer Res; 1997 Mar; 3(3):389-94. PubMed ID: 9815696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]